Carregant...
Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag
Poor graft function (PGF) is a life-threatening complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Current treatment strategies include the use of growth factors, CD34(+)-selected stem cell boost, mesenchymal stem cell transfusion, and second allo-HSCT, but these trea...
Guardat en:
| Publicat a: | J Hematol Oncol |
|---|---|
| Autors principals: | , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6097332/ https://ncbi.nlm.nih.gov/pubmed/30115080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-018-0649-6 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|